As part of a multi-year RWE initiative, AMCP Research Institute partnered with IQVIA, payers, pharmaceutical companies, and others to design payer-focused RWE standards that were published in JMCP in September, 2025.
Report: A Lexicon For Value-Based Purchasing
Value-based contracts often require significant time to reach final negotiation and implementation. Disconnect, misalignment, and lack of a common framework for value-based purchasing agreements has exacerbated these challenges. This lexicon provides a unified language for discussing and designing value-based contracts across payers, provider systems, and manufacturers.
Related
AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
AMCP launched the metabolic health thought leadership program to empower payers to shift from siloed treatment to holistic, root-cause-focused metabolic health management—redefining roles in benefit design and population outcomes—starting immediately with the new ADA 2026 CGM expansions that are reshaping coverage and access.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
